SCHEMBL4757264

SCHEMBL4757264

CCCCS(=O)(=O)c1csc(NC(=O)c2ccc(O)cc2Cl)n1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE5A O76074 1/20 0.44
PYGL P06737 1/20 0.39
GCK P35557 1/20 0.38
NPC1 O15118 3/20 0.37
RAB9A P51151 3/20 0.37
RORC P51449 3/20 0.37
SMN1; SMN2 Q16637 3/20 0.37
ALDH1A1 P00352 4/20 0.37
MAPT P10636 3/20 0.37
HPGD P15428 2/20 0.37
KDM4E B2RXH2 3/20 0.37
RXFP1 Q9HBX9 1/20 0.37
MAOB P27338 1/20 0.36
HTT P42858 2/20 0.36
TP53 P04637 2/20 0.36
LMNA P02545 1/20 0.36
CASP3 P42574 1/20 0.36
SENP8 Q96LD8 1/20 0.36
SENP7 Q9BQF6 1/20 0.36
SENP6 Q9GZR1 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4757028 0.82 NPC1 (0.46) PDE5AGCKNPC1RAB9ARORC
SCHEMBL4757140 0.80 GRM4 (0.45) NPC1RAB9ASMN1; SMN2ALDH1A1MAPT
SCHEMBL16257641 0.75 HSD17B10 (0.48) GCKNPC1RAB9ARORCSMN1; SMN2
SCHEMBL4757230 0.74 NPC1 (0.41) GCKNPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL16257681 0.74 GRM5 (0.44) PDE5AGCKNPC1RAB9ARORC
SCHEMBL16918836 0.73 RORC (0.32) PDE5AGCKNPC1RAB9ARORC
SCHEMBL4757221 0.71 NPC1 (0.48) GCKNPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL4756668 0.70 NPC1 (0.48) PDE5AGCKNPC1RAB9ASMN1; SMN2
SCHEMBL12974328 0.70 NPC1 (0.64) PDE5ANPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL16918840 0.69 THRB (0.35) NPC1RAB9ASMN1; SMN2ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2178852-B9 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LAB LC (US) 2016-06-22 EP disclosed
EP-2178852-B1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LAB LC (US) 2015-07-22 EP disclosed
US-8895752-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES L.C. (US) 2014-11-25 US disclosed
US-8895752-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES L.C. (US) 2014-11-25 US disclosed
US-20120122939-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LABORATORIES, L.C. 2012-05-17 US disclosed
US-8124632-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES, L.C. (US) 2012-02-28 US disclosed
US-20090036467-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LABORATORIES L.C. 2009-02-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120122939-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS HAVCR2, EIF2AK2, AADAC PDE5A 4694/4885PYGL 59/4885GCK 1360/4885
US-20090036467-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS HAVCR2, EIF2AK2, AADAC PDE5A 4694/4885PYGL 59/4885GCK 1360/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.